No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina / NY / Florida       

Mammography System Market Revenue to Cross USD 4B by 2027

Editor: What To Know

  • The increasing incidence of cancer cases and the growing awareness about early diagnosis of cancer among young and adult women are driving the screening procedure demand in the region.
  • In addition, growing healthcare expenditure, rising usage of novel technologies, and availability of mobile screening tools will further spur the market demand in the coming year.
  • The introduction of such mammography devices has reduced the cost of treatment, owing to the reduction in false positive and abnormal interpretation.

February 18, 2021

Mammography System Market by Product Latest Report (Analog Systems, Full Field Digital Mammography System (FFDM), Breast Tomosynthesis System), Technology (Screen Film, 2D Mammography, 3D Mammography), End-use (Hospitals, Ambulatory Surgical Centers), Regional Outlook, Price Trends, Competitive Market Share & Forecast 2027″, by Global Market Insights, Inc., the market valuation of mammography system will cross $4 billion by 2027.

The rising incidence of breast cancer coupled with continuous technological advancement in the field of mammography devices will foster market growth.

Major factors augmenting the burden of breast cancer are the increasing geriatric population, history of breast cancer, dense breast tissue, obesity, alcohol consumption, and radiation exposure. Innovation in mammography devices allows the early detection of breast cancers. The mammography machines produce exceptionally sharp images and seamless transition between imaging mode and advanced clinical application. Thus these features help in the early detection of breast cancer, thereby rendering it favorable for timely treatment protocol.

Request for a sample of this research report at https://www.gminsights.com/request-sample/detail/2637

The increasing number of product launches coupled with speedy product approval is positively impacting the mammography system market expansion. Introduction AI-based breast imaging technology is improving the clinical outcome and saving time. AI-based mammography devices can accurately and reliably classify breast tissues without any intervention. The introduction of such mammography devices has reduced the cost of treatment, owing to the reduction in false positive and abnormal interpretation. Thus, continuous technological advancements and the availability of advanced treatment options will create demand for mammography systems in foreseeable future.

Full field digital mammography (FFDM) dominated more than 66% of the market share in 2020 led by increasing adoption rate and significant improvement in clinical outcome. Moreover, these systems offer enhanced screening in young as well as dense breast tissue women. Thus, the superior benefits of full field digital mammography devices compared with other devices will boost the product demand.

Increasing use of 3D mammography devices in various applications of breast cancer is propelling the mammography system market value. The 3D mammography technology provides advanced images of breast tissues and characterization of breast lesions. Thus, availability of reimbursement to patients, low recall rates, and significant rise in detection of invasive cancer will fuel the segment growth during the forecast period.

The hospital segment is projected to reach over USD 2.5 billion by 2027. An increasing number of breast cancer cases globally will drive the number of mammography screenings in hospitals. The availability of high-end technology coupled with the presence of experienced radiologists also influences device usage. Furthermore, favorable reimbursement for mammography tests in hospitals and government initiatives will significantly contribute to the overall market revenue.

The Asia-Pacific mammography system market is expected to register a significant growth rate during the forecast period. The increasing incidence of cancer cases and the growing awareness about early diagnosis of cancer among young and adult women are driving the screening procedure demand in the region. In addition, growing healthcare expenditure, rising usage of novel technologies, and availability of mobile screening tools will further spur the market demand in the coming year.

Request for customization of this research report here.

Major players operating in the global mammography system market include Analogic Corporation, Hologic, Canon Medical System Corporation (Toshiba Medical System Corporation), Fujifilm Holding Corporation, GE healthcare, Hologic, and Siemens Healthineers. Established industry leaders are continuously involved in product development and adoption of novel technologies. These companies are focusing on the enhancement of distribution networks to boost the product reach and sales.

Table of Contents (ToC) of the report:

Chapter 3   Mammography System Market Insights

3.1    Industry segmentation

3.2    Industry landscape, 2016 – 2027 (USD Million)

3.3    Industry impact forces

3.3.1    Growth drivers

3.3.2    Industry pitfalls & challenges

3.4    Growth potential analysis

3.4.1    By product

3.4.2    By technology

3.4.3    By end-use

3.5    COVID-19 impact analysis

3.6    Regulatory landscape

3.7    Reimbursement landscape

3.8    Technology landscape

3.9    Pricing analysis

3.10    Porter’s analysis

3.11    Competitive landscape, 2020

3.12    PESTEL analysis

Browse Complete Table of Contents (ToC) at

https://www.gminsights.com/toc/detail/mammography-systems-market

About Global Market Insights, Inc.

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy